QingSong Health (HKSE:02661) Notes Receivable: HK$0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02661 QingSong Health Corp HKSE:02661
18 GF Score
Price HK$5.54
! 4 Warning Signs
View Full Analysis

What is QingSong Health Notes Receivable?

QingSong Health HKSE:02661 -3.32% 18 Notes Receivable is HK$0 Mil as of Dec. 2025. GuruFocus rates HKSE:02661 with a GF Score™ of 18/100. The stock has 4 warning signs investors should review.

QingSong Health's Notes Receivable for the quarter that ended in Dec. 2025 was HK$0 Mil.

QingSong Health Notes Receivable Related Terms

QingSong Health Notes Receivable Historical Data

* Premium members only.

The historical data trend for QingSong Health's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QingSong Health Notes Receivable Chart

QingSong Health Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00 0.00

QingSong Health Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
HKSE:02661
18GF Score
QingSong Health Corp HKSE:02661
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QingSong Health Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of HK$0 Mil mean?
QingSong Health (HKSE:02661) has a Notes Receivable of HK$0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on QingSong Health and its competitors.
Is QingSong Health's Notes Receivable too high?
QingSong Health's current Notes Receivable is HK$0 Mil. Overall, QingSong Health has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does QingSong Health's Notes Receivable compare to VEEV and BTSG?
QingSong Health's Notes Receivable of HK$0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on QingSong Health and its competitors. QingSong Health's current Notes Receivable is HK$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QingSong Health stock overvalued right now?
QingSong Health (HKSE:02661) has a current Notes Receivable of HK$0 Mil. The current Notes Receivable is HK$0 Mil. QingSong Health's overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For QingSong Health (HKSE:02661), the current Notes Receivable is HK$0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

QingSong Health Business Description

Address No. 28 Andingmen East Street, 7th floor, Building F, Yonghe Mansion, Dongcheng District, Beijing, CHN
QingSong Health Corp is a technology-driven one-stop platform in China, focusing on providing comprehensive health services and health insurance solutions. It offers healthcare-related services, including early disease screening promotion and consultancy, health examinations and consultations, medical appointment services, and the sale of health supplements. It prominently offers health insurance products providing coverage for illness and medical expenses, typically for one year or less. The company also offers critical illness insurance, which provides a lump-sum payment if the policyholder is diagnosed with specified serious illnesses. It derives revenue from the provision of Healthcare-related Services. Geographically, it operates only in China.
18GF Score

Get the complete analysis for HKSE:02661

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$5.54
Price